Atricure Inc
NASDAQ:ATRC 11:37:11 AM EDT
| Market Cap (Intraday) | 2.96B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $65.08 |
| 50-Day MA | $63.80 |
| 200-Day MA | $49.47 |
AtriCure, Inc. Stock, NASDAQ:ATRC
7555 Innovation Way, Mason, Ohio 45069
United States of America
Phone: +1.513.755.4100
Number of Employees: 730
Description
AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.